Symbiosis Dubai's MBA Class of 2025 Achieves 98% Internship Success in its First Year
Within just one year of its launch, Symbiosis Dubai’s MBA program has…
Bybit Crypto Insights Report: Markets Mixed After October 2025 Rate Cut Amid Uncertainty Over December Decision
DUBAI, UAE, Oct. 31, 2025 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency exchange…
Guardant Health to Share Data Supporting Critical Role of Blood-Based Testing in Improving Cancer Screening Adherence at ACG 2025
Expanded cohort reiterates strong adherence rate of over 90% for Shield blood-based…
Tirupati, India, Among Asia's Most Affordable Summer Destinations in 2025: Agoda
Digital travel platform Agoda has revealed its list of the most budget-friendly…
Subcutaneous RYBREVANT(amivantamab) delivers promising 45 percent overall response rate with median duration of response of 7.2 months in recurrent or metastatic head and neck cancer
Responses were rapid and durable, and tumour shrinkage was observed in 82…
GIGABYTE Announces Availability of 27″ QHD 280Hz WOLED Gaming Monitor MO27Q28G with 4-Sided Borderless Design
TAIPEI, Sept. 30, 2025 /PRNewswire/ -- GIGABYTE, the world's leading computer brand,…
Las Vegas Kicks Off The Fabulous 5Day Sale Today
First Ever City-Wide Sale Available Sept. 22-26; Offers Include up to 50%…
C4 Therapeutics Presents Cemsidomide Phase 1 Multiple Myeloma Data Supporting Potential Best-in-Class Profile at the International Myeloma Society Annual Meeting
September 20, 2025 11:00 ET | Source: C4 Therapeutics, Inc. Cemsidomide in…
Five Point Announces Expiration and Results of Cash Tender Offer for Any and All Outstanding 10.500% Initial Rate Senior Notes Due 2028
IRVINE, Calif.--(BUSINESS WIRE)--Five Point Holdings, LLC (“Five Point”) (NYSE: FPH) announced today…
ALCOR Scientific Transforms ESR Testing: Extends Blood Sample Stability from 4 to 28 Hours
Diagnostic Company's iSED Analyzers Deliver Seven-Fold Stability Increase to Improve Accuracy, Efficiency,…